AUG 12, 2026 · PHASE 1 TRIAL
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov
Phase 1 bioavailability study with completed recruitment but no results posted; addresses pharmacokinetic endpoints and safety in a small population with advanced lung cancer.
Reported
Sample size62
Study phasePhase 1
Primary outcome measure (Part 1 a…Area under the concentration-time curve (AU…